Search Within

Christina Bello

  1. "2012"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
Groups
  1. Bone Marrow Transplant (4)
  2. Center for Hematologic Malignancies (4)
  3. Department of Medicine (4)
  4. Hematologic Malignancies, Division of (4)
  5. Survivorship Research (4)
  6. Myeloma (3)

More Groups

People
  1. Heather Landau (4)
  2. Elizabeth Hoover (3)
  3. Elyn Stubblefield (3)
  4. Hani Hassoun (3)
  5. Alexander Lesokhin (1)
  6. Daniel Fein (1)

More People

Years
  1. 2012 (4)
Publications
  1. Biology of Blood and Marrow Transplantation (2)
  2. Blood (1)
  3. Leukemia and Lymphoma (1)
Publishers
  1. Elsevier Inc. (2)
  2. American Society of Hematology (1)
  3. Taylor & Francis Group (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk-adapted melphalan and stem cell transplant for systemic light chain amyloidosis: A single institution experience
    Meeting Abstract

    Landau, H.; Fein, D. E.; Hassoun, H.; Bello, C.; Chou, J. F.; Devlin, S.; Giralt, S.; Comenzo, R. L.
    Blood (2012)

    Fulltext@MSK | Save
  • Maintained hematologic and organ responses following risk adapted stem cell transplant (SCT) in systemic light-chain amyloidosis (AL) using bortezomib and dexamethasone as consolidation therapy
    Meeting Abstract

    Landau, H. J.; Hassoun, H.; Rosenzweig, M. A.; Bello, C.; Hoover, E.; Riedel, E.; Comenzo, R. L.
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Urinary excretion of epinephrine and dopamine correlates with efficiency of G-CSF mobilized stem cells in patients with AL amyloidosis
    Meeting Abstract

    Landau, H. J.; Bello, C.; Hoover, E.; Riedel, E.; Frenette, P.; Comenzo, R. L.
    Biology of Blood and Marrow Transplantation (2012)

    Fulltext@MSK | Save
  • Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myeloma with Internatinal Staging System stage II or III, or extramedullary disease
    Journal Article

    Landau, H.; Pandit-Taskar, N.; Hassoun, H.; Cohen, A.; Lesokhin, A.; Lendvai, N.; Drullinsky, P.; Schulman, P.; Jhanwar, S.; Hoover, E.; more...
    Leukemia and Lymphoma (2012)

    Fulltext@MSK | Save